000			03476nam a22006617a 4500
008			190108s20192019 xxu||||| |||| 00| 0 eng d
022			_a1878-0938
024			_a10.1016/j.carrev.2018.11.016 [doi]
024			_aS1553-8389(18)30531-1 [pii]
040			_aOvid MEDLINE(R)
099			_a30581088
245			_aTakotsubo syndrome: State-of-the-art review by an expert panel - Part 2. [Review]
251			_aCardiovascular Revascularization Medicine. 20(2):153-166, 2019 02.
252			_aCardiovasc Revasc Med. 20(2):153-166, 2019 02.
252			_zCardiovasc Revasc Med. 2018 Nov 17
253			_aCardiovascular revascularization medicine : including molecular interventions
260			_c2019
260			_fFY2019
265			_saheadofprint
265			_sppublish
266			_d2019-01-08
268			_aCardiovascular Revascularization Medicine. 2018 Nov 17
501			_aAvailable in print through MWHC library: 2002 - present
520			_aCopyright (c) 2018 Elsevier Inc. All rights reserved.
520			_aIn part 2 of this two-part manuscript on takotsubo syndrome (TTS), we discuss typical biomarkers (particularly excess catecholamines and what kinds of electrocardiographic information operators should look for) and numerous complications the syndrome can cause. This consensus paper is the result of a multinational effort aiming to summarize the current state of the art on TTS. Several novel and unique sections are emphasized in this document, including the current state of the art on genetics of takotsubo syndrome, microRNAs (miRs), racial differences, role of cardiac spectroscopy and intracoronary imaging, as well as mechanical circulatory support. New structured algorithms are also proposed to aid clinicians in the decision-making process as well as future directions for research given the current lack of evidence-based medical approaches.
546			_aEnglish
650			_a*Takotsubo Cardiomyopathy
650			_aBiomarkers/bl [Blood]
650			_aCardiac Imaging Techniques
650			_aCatecholamines/bl [Blood]
650			_aClinical Decision-Making
650			_aConsensus
650			_aDecision Support Techniques
650			_aDisease Progression
650			_aElectrocardiography
650			_aHumans
650			_aPatient Selection
650			_aPredictive Value of Tests
650			_aRecurrence
650			_aTakotsubo Cardiomyopathy/di [Diagnosis]
650			_aTakotsubo Cardiomyopathy/mo [Mortality]
650			_aTakotsubo Cardiomyopathy/pp [Physiopathology]
650			_aTakotsubo Cardiomyopathy/th [Therapy]
650			_aTreatment Outcome
650			_aVentricular Function, Left
651			_aMedStar Heart & Vascular Institute
657			_aJournal Article
657			_aReview
700			_aBen-Dor, Itsik
700			_aDias, Andre
700			_aGarcia-Garcia, Hector M
700			_aKajita, Alexandre H
700			_aOzaki, Yuichi
700			_aWaksman, Ron
790			_aAkasaka T, Akashi YJ, Akin I, Ben-Dor I, Brunetti ND, Christensen TE, Christian Napp L, Dawson D, Dias A, Eitel I, El-Battrawy I, Figueredo VM, Franco E, Garcia-Garcia HM, Hebert K, Jaguszewski M, Kajita AH, Kurisu S, Lerman A, Madias JE, Nunez Gil IJ, Ozaki Y, Pelliccia F, Salmoirago-Blotcher E, Santoro F, Sharkey SW, Waksman R
856			_uhttps://dx.doi.org/10.1016/j.carrev.2018.11.016 _zhttps://dx.doi.org/10.1016/j.carrev.2018.11.016
942			_cART _dArticle
999			_c3954 _d3954